The Medicines Company (MDCO)

[smittypa]

Mea culpa on APB 700 potential. Did some research, and it looks like generic Propofol (by extrapolation) wholesales for about $17/vile, with annual sales, US & Euro combined, at close to $3 billion annually. I was assuming a much higher price, for ABP 700, than the market will bear. A $50/vile price, with superior efficacy, could possibly gain 33% of the 180 million annual anesthesia patients, or in the range of $3 billion annually. Obviously, the price will be negotiated with medicare/medicaid, and the likes of express scripts, so there is a great deal of potential variation, down the road.